Smith Group Asset Management’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3
Closed -$1K 310
2021
Q4
$1K Hold
3
﹤0.01% 364
2021
Q3
$1K Hold
3
﹤0.01% 367
2021
Q2
$2K Hold
3
﹤0.01% 357
2021
Q1
$3K Sell
3
-92
-97% -$98K ﹤0.01% 316
2020
Q4
$88K Hold
95
0.01% 207
2020
Q3
$98K Hold
95
0.01% 199
2020
Q2
$96K Sell
95
-1
-1% -$929 0.01% 196
2020
Q1
$84K Sell
96
-1
-1% -$994 ﹤0.01% 223
2019
Q4
$104K Hold
97
﹤0.01% 238
2019
Q3
$89K Buy
97
+13
+15% +$14.3K ﹤0.01% 245
2019
Q2
$95K Hold
84
﹤0.01% 243
2019
Q1
$114K Sell
84
-276
-77% -$374K ﹤0.01% 251
2018
Q4
$417K Sell
360
-8
-2% -$8.99K 0.01% 201
2018
Q3
$559K Buy
368
+41
+13% +$63.1K 0.02% 194
2018
Q2
$512K Buy
327
+7
+2% +$9.13K 0.01% 198
2018
Q1
$369K Sell
320
-260
-45% -$342K 0.01% 207
2017
Q4
$687K Hold
580
0.02% 185
2017
Q3
$780K Buy
580
+161
+38% +$170K 0.03% 181
2017
Q2
$338K Sell
419
-4
-0.9% -$2.79K 0.01% 235
2017
Q1
$261K Hold
423
0.01% 241
2016
Q4
$226K Sell
423
-4
-0.9% -$2K 0.01% 239
2016
Q3
$221K Hold
427
0.01% 243
2016
Q2
$175K Sell
427
-12
-3% -$5.5K 0.01% 275
2016
Q1
$234K Sell
439
-1,007
-70% -$502K 0.01% 196
2015
Q4
$1.1M Sell
1,446
-247
-15% -$164K 0.03% 168
2015
Q3
$928K Buy
+1,693
New +$1.03M 0.04% 167

Other funds holding KYNB

Smith Group Asset Management's KYNB Position: Q1 2022 in Review

Smith Group Asset Management sold out of Kyntra Bio (KYNB) in Q1 2022, closing a stake of 3 shares — an estimated $1K sold.

Smith Group Asset Management first reported a position in KYNB in Q3 2015 and held it in 26 quarters. The position peaked at $1.1M in Q4 2015. 156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

  • Smith Group Asset Management reported no remaining Kyntra Bio position as of Q1 2022 after selling out during the quarter.
  • Smith Group Asset Management sold 3 Kyntra Bio shares in Q1 2022, an estimated $1K.
  • Smith Group Asset Management first reported a position in Kyntra Bio in Q3 2015 and held it in 26 quarters.
  • Smith Group Asset Management's Kyntra Bio position peaked at $1.1M in Q4 2015.
  • 156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.